Lina Maria Candia
Research group
- Translational oncology in upper gastrointestinal cancers Pre-doctoral researcher (R1)
About me
Graduated in Medicine and Surgery from the Complutense University of Madrid (2017). After completing her clinical rotations in Medical Oncology at the Gregorio Marañón University General Hospital, she began her specialist training in Medical Oncology at the University Clinical Hospital of Valencia (2018–2023). During this period, she developed clinical and scientific skills, with a particular interest in gastrointestinal tumors. From the outset, she participated in collaborative projects with ESMO (European Society for Medical Oncology) to create online, interactive content that would facilitate learning and scientific updates for other young oncologists in a dynamic and collaborative format—the “ESMO Living Guidelines.” Since June 2023, she has been part of Hospital Clínic de Barcelona, w
Featured publications
-
HER2DX ERBB2 score in advanced HER2-positive gastric cancer treated with trastuzumab and chemotherapy
Authors:Reference: Esmo Open 2025. -
Correlation between tumor regression grades (TRG) and overall survival in locally advanced resectable gastroesophageal adenocarcinoma (LAR-GEA): Real-world data (RWD) analysis
Authors:Reference: Annals Of Oncology 2025. -
Prognostic value and clinical implication of ctDNA profiling in metastatic pancreatic ductal adenocarcinoma patients: A multicenter European study
Authors:Reference: Annals Of Oncology 2025. -
HER2DX ERBB2 mRNA assay following trastuzumab-based chemotherapy in HER2-positive (HER2+) advanced gastric cancer (AGC)
Authors:Reference: Annals Of Oncology 2024. -
CT-based radiomics models to predict progression in locally advanced head and neck cancer treated with definitive chemoradiation
Authors:Reference: Annals Of Oncology 2023. -
Prediction of relapse in colon cancer patients by machine learning models combining radiomics and deep features extracted from baseline computed tomography
Authors:Reference: Annals Of Oncology 2022. -
GUT VASCULAR BARRIER IMPAIRMENT LEADS TO INTESTINAL BACTERIA DISSEMINATION AND COLORECTAL CANCER METASTASIS TO LIVER
Authors:Reference: Esmo Open 2021. -
Prognosis for patients with oligometastatic breast cancer who achieve NED status after systemic and local therapy
Authors:Reference: Annals Of Oncology 2020.
